PharmaDrug’s Sairiyo Therapeutics Starts Phase 1 Trial
PharmaDrug's Sairiyo Therapeutics Starts Phase 1 Trial Exciting news in the psychedelic investing world! PharmaDrug's Sairiyo Therapeutics has just received ...
Read morePharmaDrug's Sairiyo Therapeutics Starts Phase 1 Trial Exciting news in the psychedelic investing world! PharmaDrug's Sairiyo Therapeutics has just received ...
Read moreClearmind Secures U.S. Patent for Binge Treatment In a groundbreaking development for the world of psychedelic medicine, Clearmind Medicine has
Bright Green Partners with Benuvia for Raw Materials Bright Green Corporation, a pioneering player in the American cannabis industry, proudly
Sustained Antidepressant Response With Psychedelic Microdosing The revolutionary field of psychedelic science has been making significant strides recently, and a
atai Life Sciences Q2 2024 Financial Highlights atai Life Sciences, a leader in psychedelic biotech, has recently released its financial
Cybin Advances CYB003 for Major Depression Treatment Psychedelic therapy is making impressive strides in the world of mental health treatment,
MindMed Q2 2024 Financials and Business Insights MindMed, a leading company in the psychedelic medicine sector, has recently released its
Filament Health Expands Intellectual Property Portfolio Filament Health, a front-runner in the psychedelic drug development sector, has recently revealed a
Positive Phase 1b Results for atai’s DMT Film In a promising breakthrough for the burgeoning psychedelic medicine industry, atai Life
PharmAla Announces FDA Decision on MDMA Therapy The psychedelic renaissance is gaining momentum, and PharmAla is at the forefront of